Avive Automated External Defibrillator

by Avive Solutions  · Based in United States → — Connecting the Chain of Survival.
Cardiology Critical Care Emergency Medicine
Claim this tool
Is this the maker? Claim the company →

Contact avive solutions for pricing.
Regulatory Status Disclosed

Overview

The Avive Automated External Defibrillator (AED) is a handheld, portable medical device designed for emergency treatment of sudden cardiac arrest (SCA). It is the only market-ready AED with Cellular, WiFi, GPS, and Bluetooth connectivity, powering Avive’s RealConnect Technology. This innovative system integrates with 911 centers through a partnership with RapidSOS, enabling the transfer of critical incident data (ECG, usage timestamps, shock analysis) to telecommunicators, EMS, and medical professionals. The Avive AED provides voice prompts and visual indicators to guide both trained and untrained users through a resuscitation sequence, including automatic cardiac rhythm analysis and shock delivery when needed. The RealConnect Platform also facilitates automated remote monitoring and maintenance of deployed Avive AEDs, ensuring they are properly maintained and functional. The device is indicated for adult and pediatric patients over 1 year of age, with a dedicated Child Mode for younger or smaller patients.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Handheld and ultra-portable (2.1 pounds)
  • Full suite of connectivity: Cellular, WiFi, GPS, and Bluetooth
  • RealConnect Technology for 911 integration via RapidSOS partnership
  • Automated remote monitoring and maintenance of AEDs
  • Rapid Incident Data Transfer (ECG, usage timestamps, shock analysis) to 911/EMS
  • Voice prompts and visual indicators for trained and untrained users
  • Automatic cardiac rhythm analysis and shock delivery
  • Designed for adult and pediatric use (with Child Mode)
  • Rechargeable battery
  • Daily, weekly, and monthly self-tests

Use Cases

  • Emergency treatment of sudden cardiac arrest (OHCA)
  • Deployment in police and fire departments
  • Placement in higher education institutions, cities, and counties
  • Use in nationwide gym chains, small businesses, families, and individuals
  • Improving survival rates by connecting the chain of survival (911, bystanders, first responders, hospitals)
  • Community-wide deployment through programs like '4 Minute City'

What Physicians Need to Know

ECG/EKG Analysis Capability
The Avive AED measures the patient's electrocardiogram (ECG) and utilizes a patented machine learning algorithm, the Rhythm Recognition Detector, to accurately identify shockable and non-shockable cardiac rhythms.
Arrhythmia Detection Accuracy
The Rhythm Recognition Detector has been extensively trained using diverse databases of adult and pediatric ECGs, demonstrating over 99% diagnostic accuracy for shockable and non-shockable rhythms. Its performance surpasses the sensitivity and specificity recommendations set by the American Heart Association.
Cardiac Monitoring Integration
The Avive Connect AED features advanced connectivity (cellular, Wi-Fi, GPS) and integrates with 911 call centers via its QuickRescueu2122 feature, automatically alerting emergency services upon activation and sharing critical incident data. The REALConnectu2122 platform enables remote monitoring of device health, status, and location, while post-event data, including ECG recordings and shock analysis, can be rapidly accessed and shared with healthcare providers.
AHA/ACC Guideline Alignment
The device's rhythm recognition performance exceeds American Heart Association recommendations for sensitivity and specificity. It is designed for emergency treatment of sudden cardiac arrest by analyzing ECG and delivering defibrillation for ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT), aligning with established guidelines for AED use.
Real-Time Alert Capability
During a rescue, the Avive Connect AED provides real-time audio and visual instructions, including continuous CPR coaching with an audible metronome. Through QuickRescueu2122 and REALConnectu2122, it automatically alerts 911 and device owners (via text/email) when the AED is in use or requires attention.
Physician Tip

For healthcare providers, the Avive Connect AED offers significant advantages beyond basic defibrillation. Its advanced connectivity and integration with 911 through QuickRescueu2122 can provide crucial pre-arrival data, such as device location, event timeline, shock information, and even ECG data, enabling more informed and rapid clinical decision-making upon patient arrival. The remote monitoring capabilities of REALConnectu2122 ensure device readiness and streamline maintenance, reducing the risk of an unavailable AED during an emergency. The high accuracy of its machine learning algorithm for arrhythmia detection, exceeding AHA recommendations, provides confidence in appropriate shock delivery. Furthermore, the ability to quickly access post-event data facilitates comprehensive patient care and quality improvement initiatives.

The Avive Connect AED boasts a robust connectivity suite, including cellular, Wi-Fi, and GPS, which powers its REALConnectu2122 platform. This enables seamless integration with emergency response systems, most notably through its partnership with RapidSOS for direct 911 integration via QuickRescueu2122. This integration allows for automatic transmission of critical incident data to 911 telecommunicators and subsequently to EMS and hospitals. The platform also supports remote fleet management, daily self-tests, and location tracking, with alerts sent to device owners. Post-event data capture is streamlined, allowing for rapid sharing of ECG recordings, timestamps, and shock analysis with first responders and healthcare providers, often via a QR code or cloud-based software.

Details

Category Cardiology AI, Triage & ER/ICU AI
Pricing Contact avive solutions for pricing. — N/A
DeploymentPhysical device deployment in various public and private settings.
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Yes AI-estimated

The Avive Automated External Defibrillator (AED) System received US FDA pre-market approval (PMA P210015) on October 31, 2022, for the emergency treatment of individuals exhibiting symptoms of cardiac arrest.
Integrations
EHR Not specified
Specialties Cardiology, Critical Care, Emergency Medicine

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Avive Automated External Defibrillator

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

FDA
Avive Automated External Defibrillator (AED) System
The FDA approved the Avive Automated External Defibrillator (AED) System on October 31, 2022, for emergency treatment of individuals exhibiting symptoms of cardiac arrest. This regulatory announcement details the device's indications for use in adult and pediatric patients over 1 year of age.
2022-10
Journal of the American Heart Association
Convolution Neural Network Algorithm for Shockable Arrhythmia Classification Within a Digitally Connected Automated External Defibrillator
Published in March 2023, this peer-reviewed article details the high diagnostic performance of a Convolutional Neural Network (CNN) algorithm for classifying shockable and nonshockable arrhythmias within the Avive AED. The study highlights the algorithm's accuracy and robustness against noise artifacts.
2023-03
FDA Post-Approval Studies (PAS) Database
Avive AED Post-Approval Study
This ongoing post-approval study, initiated after the Avive AED's FDA approval, is a prospective observational study comparing the Avive AED Rhythm Recognition Detector performance to objective performance criteria. Initial data shows an overall sensitivity for shockable rhythms of 93% and specificity for non-shockable rhythms of 98%.
2022-10
Wikipedia (citing an August 2023 award)
Avive Connect AED Wins Two International Design Excellence Awards (IDEA)
In August 2023, the Avive Connect AED received two International Design Excellence Awards (IDEA) from the Industrial Designers Society of America (IDSA) in the service design and medical and health categories.
2023-08
The Sentinel (cited by Wikipedia)
New initiative brings AEDs, CPR education to Cumberland County
A February 2022 news article reported on an initiative that brought Avive AEDs and CPR education to Cumberland County, Pennsylvania, as part of the 4 Minute Community program.
2022-02
The Patriot-News (cited by Wikipedia)
Central Pa. community set to become national leader in lifesaving care that saved Damar Hamlin
In January 2023, a news report highlighted a Central Pennsylvania community's adoption of the Avive 4 Minute City program, aiming to become a national leader in lifesaving care.
2023-01
unknown (cited by Wikipedia)
Forsyth County Among First In Country To Implement 4 Minute City Program
In the summer of 2023, Forsyth County, Georgia, launched its 4 Minute City program, deploying networks of Avive Connect AEDs to ensure accessibility within four minutes of a cardiac arrest incident.
2023-06

Videos

Product demos, reviews, and walkthroughs for Avive Automated External Defibrillator.

View all on YouTube

Frequently Asked Questions

The Avive AED utilizes a machine-learning algorithm for highly accurate arrhythmia classification, exceeding 99% diagnostic accuracy for shockable and non-shockable rhythms. Its RealConnect Technology integrates cellular, WiFi, GPS, and Bluetooth to automatically transmit critical incident data, such as ECGs, usage timestamps, and shock analysis, directly to 911 centers, EMS, and medical professionals, streamlining information flow and aiding rapid decision-making.
The Avive AED has received U.S. FDA pre-market approval (PMA), which is the agency's highest level of approval, on October 31, 2022. It is designated for prescription use only and conforms to various international standards for medical electrical equipment and software, including IEC 60601 and IEC 62304.
The Avive AED stands out with its advanced machine-learning algorithm for arrhythmia detection and its comprehensive RealConnect platform, offering cellular, WiFi, GPS, and Bluetooth connectivity. This enables direct integration with 911 systems and remote monitoring for automated maintenance checks, which is a significant advancement over many traditional, standalone AEDs.
The Avive Connect AED is priced at $1899, which includes the first year of its REALConnect services. Subsequent annual REALConnect software subscriptions cost $199. This model, which includes a rechargeable internal battery, aims to be competitively priced while offering advanced connectivity features that may reduce long-term maintenance costs associated with disposable batteries in traditional AEDs.
The Avive AED is contraindicated for use on patients who are responsive or conscious. Physicians should also be aware that improper maintenance or the use of unauthorized accessories can impair device function or void the warranty. Detailed warnings and precautions are provided in the Avive AED Owner's Manual.
The Avive AED's software is designed with cybersecurity in mind, incorporating secure software updates, communication authentication, and integrity checks to ensure reliable data transfer and safe communication. This helps protect the privacy and security of sensitive patient data, such as ECG readings and shock analysis, as it is transmitted to emergency services and healthcare providers.
The Avive AED's RealConnect Technology enables direct integration with 911 centers through partnerships like RapidSOS, allowing for real-time alerts and location data to be shared. It also facilitates rapid transfer of incident data, including ECGs and shock analysis, to EMS and medical professionals, which aids in informed decision-making and smoother patient care transitions to hospitals.

Compare Avive Automated External Defibrillator

VS
Avive Automated External Defibrillator vs Vivid E80
Cardiology AI Adjacent · 65/100
These tools are adjacent rather than direct competitors, both contributing to cardiology but in distinct ways. The Avive Connect AED is an emergency treatment device for out-of-hospital cardiac…
VS
Avive Automated External Defibrillator vs SOMATOM X.ceed
Cardiology AI Adjacent · 65/100
These tools are adjacent rather than direct competitors, despite both being relevant in emergency and cardiac care. Tool A is an automated external defibrillator focused on immediate life-saving…
VS
AHI System vs Avive Automated External Defibrillator
Cardiology AI Adjacent · 60/100
Tool A is an AI-powered software for real-time predictive analytics of hemodynamic instability within hospital environments, enabling early clinical intervention. In contrast, Tool B is a physical, portable…
VS
Caption Interpretation Automated Ejection Fraction Software vs Avive Automated External Defibrillator
Cardiology AI Adjacent · 60/100
Tool A is an AI-powered software designed for diagnostic purposes, specifically automating left ventricular ejection fraction calculations from cardiac ultrasound images for early heart disease detection. In contrast,…

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-04-20 | First Added: 2026-04-20

Investors who backed Avive Automated External Defibrillator

Funded through the company that built this tool.

Rock Health Capital
VC T3
San Francisco, United States
$250k-$1M
Rock Health Capital is the dedicated investment vehicle aligned with the Rock Health platform, the long-running digital health community, research, and seed…
AI/ML in Healthcare Care Delivery / Tech-Enabled Services
AI Tool Finder
AI-powered search. Results may not be comprehensive.